Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
US Food and Drug Administration extends action date for dapagliflozin by three months
-
AstraZeneca to present new healthcare economics data demonstrating cost-effectiveness of BRILIQUE at ISPOR EU
-
AstraZeneca and Forest Laboratories to initiate phase III clinical trials for ceftazidime/avibactam to treat serious Gram-negative bacterial infections
-
AstraZeneca increases investment in China with new $200 million manufacturing facility
-
AstraZeneca enters into a settlement agreement with Accord Healthcare, Inc. and Intas Pharmaceuticals Ltd regarding US SEROQUEL XR® patent litigation
-
BRILIQUE receives a positive preliminary medical benefit assessment for the majority of ACS patients in Germany as part of new AMNOG review process
-
AstraZeneca enters into a settlement agreement with Handa Pharmaceuticals regarding US SEROQUEL XR® patent litigation
-
AstraZeneca announces first approval of FASLODEX™ (fulvestrant) in Japan
-
KOMBOGLYZE™ (saxagliptin and metformin HCl immediate-release) receives positive CHMP opinion in the European Union for the treatment of type 2 diabetes
-
AstraZeneca announces top-line results from SATURN study
Latest articles and press releases
All of our latest press releases and articles are available to explore
